ストックスクリーナーアプリを入手
17.65
0.28%
-0.05
アフターアワーズ：
17.84
0.19
+1.08%
前日終値:
$17.70
開ける：
$17.8
24時間の取引高:
11.35M
Relative Volume:
1.06
時価総額：
$20.55B
収益：
$14.57B
当期純損益:
$-296.50M
株価収益率:
-68.15
EPS:
-0.259
ネットキャッシュフロー:
$1.64B
1週間 パフォーマンス:
-0.95%
1か月 パフォーマンス:
+5.69%
6か月 パフォーマンス:
+23.08%
1年 パフォーマンス:
+96.55%
1日の値動き範囲:
$17.55
$17.88
1週間の範囲:
$17.31
$17.88
52週間の値動き範囲:
$8.735
$18.07
Viatris Inc Stock (VTRS) Company Profile
Compare VTRS vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
17.65 | 20.54B | 14.57B | -296.50M | 1.64B | -0.259 |
TAK
Takeda Pharmaceutical Co Adr
|
16.72 | 55.69B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.95 | 43.77B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.72 | 36.19B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
74.39 | 32.25B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
519.01 | 26.29B | 3.17B | 1.29B | 1.01B | 27.09 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-09 | アップグレード | UBS | Neutral → Buy |
| 2026-01-16 | アップグレード | Argus | Hold → Buy |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-15 | 開始されました | Truist | Buy |
| 2025-06-06 | 開始されました | Goldman | Neutral |
| 2024-07-19 | 再開されました | Jefferies | Buy |
| 2023-10-23 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-06-23 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2023-04-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2023-02-17 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-27 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-10 | アップグレード | UBS | Sell → Neutral |
| 2022-11-08 | アップグレード | Piper Sandler | Underweight → Neutral |
| 2022-10-21 | 再開されました | Jefferies | Hold |
| 2022-06-14 | 開始されました | UBS | Sell |
| 2022-05-10 | ダウングレード | Piper Sandler | Neutral → Underweight |
| 2022-03-01 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-01 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-06-15 | 開始されました | Citigroup | Neutral |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2021-03-08 | ダウングレード | Goldman | Buy → Neutral |
| 2021-03-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-02-26 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2021-01-05 | 開始されました | Argus | Hold |
| 2020-12-14 | 開始されました | Bernstein | Mkt Perform |
すべてを表示
Viatris Inc (VTRS) 最新ニュース
Viatris Inc (VTRS) Income Statement - TradingKey
Viatris Inc (VTRS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viatris Inc. stock rises Monday, outperforms market - MarketWatch
Viatris stock hits 52-week high at $17.68 - Investing.com
Viatris Inc (VTRS) Cash Flow - TradingKey
VTRS|Viatris Inc|Price:17.635|Chg%:+0.395 - TradingKey
Viatris, Inc. Revenue Breakdown – BX:VTRS - TradingView
Viatris (VTRS) Q4 2025 Earnings Call Transcript - Fortune
Viatris Inc. Revenue Breakdown – NASDAQ:VTRS - TradingView
Viatris, Inc. (VTRS) Q1 2023 Earnings ReportResults, Call & Slides - TipRanks
Viatris, Inc. (VTRS) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
PFE5282054 Bond Profile — Key Metrics - TradingView
Viatris, Inc. (VTRS) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks
Viatris, Inc. Revenue Breakdown – LSX:A2QAME - TradingView
Viatris Inc (VTRS) Valuation: PE, PB & Fair Value Analysis - TradingKey
PFE5003244 Bond Profile — Key Metrics - TradingView
Viatris Inc. stock rises Thursday, outperforms market - MarketWatch
PFE5282056 Bond Profile — Key Metrics - TradingView
Viatris Inc (VTRS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Viatris Inc. (VTRS) Stock Forecasts - Yahoo Finance
Viatris Inc. stock falls Wednesday, underperforms market - MarketWatch
Viatris, Inc. (VIA) Q1 2023 Earnings ReportResults, Call & Slides - TipRanks
Viatris’ Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
Viatris, Inc. (VIA) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
Viatris Inc. stock rises Tuesday, outperforms market - MarketWatch
Viatris Inc. stock falls Monday, underperforms market - MarketWatch
Viatris, Inc. (VIA) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks
Viatris, Inc. (VIA) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Viatris, Inc. (1VTRS) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks
PFE5003242 Bond Profile — Key Metrics - TradingView
Khaitan & Co Advised Viatris Inc. On Secondary Sale Of Shares Held in Biocon - BW Legal World
Is Viatris (VTRS) Reframing Its Musculoskeletal Strategy Through the AAOS Pain Management Partnership? - Sahm
Viatris stock hits 52-week high at $17.54 By Investing.com - Investing.com South Africa
Viatris stock hits 52-week high at $17.54 - Investing.com UK
Khaitan & Co, JSA, TT&A, Baker & McKenzie act on Viatris Inc's ₹3,680 crore exit from Biocon - Bar and Bench
PFE5282058 Bond Profile — Key Metrics - TradingView
Viatris Inc (VTRS) Stock Up 3.8% but GF Value Says Overvalued -- GF Score: 58/100 - GuruFocus
Viatris (VTRS) Q1 2026 Earnings Call Transcript - Fortune
Viatris Inc. stock rises Wednesday, outperforms market - MarketWatch
Viatris Looks to New Launches and Cost Savings for Long-Term Growth - Morningstar
XS332542958 Bond Profile — Key Metrics - TradingView
ETFs Investing in Viatris, Inc. Stocks - TradingView
Mylan to sell up to $363 million stake in India’s Biocon, term sheet shows - WTVB
Viatris unit Mylan plans to sell stake worth up to $363 million in Biocon - Business Standard
Mylan to sell up to $363 million stake in India's Biocon, term sheet shows - Reuters
(VTRS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Viatris shares break six-session winning streak - MSN
BofA Securities Maintains Viatris(VTRS.US) With Sell Rating, Raises Target Price to $14 - Moomoo
Viatris Inc. stock falls Thursday, underperforms market - MarketWatch
Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? - The Motley Fool
Should Value Investors Buy Viatris (VTRS) Stock? - Yahoo Finance
Viatris Inc (VTRS) 財務データ
収益
当期純利益
現金流量
EPS
2.75%
0.06%
大文字化:
|
ボリューム (24 時間):